Journal of Clinical Endocrinology & Metabolism, Vol 62, 922-927, Copyright © 1986 by Endocrine Society

ARTICLES

Glucose storage is a major determinant of in vivo "insulin resistance" in subjects with normal glucose tolerance

S Lillioja, DM Mott, JK Zawadzki, AA Young, WG Abbott and C Bogardus

In vivo "resistance" to the action of insulin on glucose uptake is commonly found in obesity and is characteristic of noninsulin-dependent diabetes mellitus in obese subjects. To investigate the relationship among glucose uptake, glucose oxidation, and nonoxidative glucose disposal (storage) in subjects with normal glucose tolerance, we studied 25 caucasians and 79 southwestern American Indians, including lean and obese subjects in both groups. The euglycemic clamp technique with simultaneous indirect calorimetry was used to determine rates of glucose uptake and glucose oxidation. These studies were performed at two rates of insulin infusion (40 and 400 mU/m2 X min), with resulting mean plasma insulin concentrations of 113 and 1839 microU/ml, respectively. At the lower insulin infusion rate, there was no glucose storage in subjects with a glucose uptake rate of about 2.2 mg/kg fat free mass X min. In contrast, glucose storage accounted for over 45% of the glucose disposal in subjects with glucose uptake rates over 7.0 mg/kg fat free mass X min studied at similar insulin concentrations. At the high insulin infusion rate, over 70% of the difference in glucose uptake between subjects with a low or high capacity for glucose disposal was due to glucose storage. These studies demonstrated that in normal subjects at both physiological and maximally stimulating plasma insulin concentrations, glucose storage is a major factor in distinguishing between those with low or high rates of insulin-mediated glucose disposal. Since glucose storage may be a specifically activated process, we hypothesize that failure to activate glucose storage is a major defect causing in vivo insulin resistance in subjects with normal glucose tolerance.

This article has been cited by other articles:

				M. J. Toth, B. C. Cooper, R. E. Pratley, A. Mari, D. E. Matthews, and P. R. Casson Effect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1035 - E1045. [Abstract] [Full Text] [PDF]

				M. Bajaj, S. Suraamornkul, A. Romanelli, G. W. Cline, L. J. Mandarino, G. I. Shulman, and R. A. DeFronzo Effect of a Sustained Reduction in Plasma Free Fatty Acid Concentration on Intramuscular Long-Chain Fatty Acyl-CoAs and Insulin Action in Type 2 Diabetic Patients Diabetes, November 1, 2005; 54(11): 3148 - 3153. [Abstract] [Full Text] [PDF]

				J. He and D. E. Kelley Muscle glycogen content in type 2 diabetes mellitus Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E1002 - E1007. [Abstract] [Full Text] [PDF]

				M. Bajaj, S. Suraamornkul, S. Kashyap, K. Cusi, L. Mandarino, and R. A. DeFronzo Sustained Reduction in Plasma Free Fatty Acid Concentration Improves Insulin Action without Altering Plasma Adipocytokine Levels in Subjects with Strong Family History of Type 2 Diabetes J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4649 - 4655. [Abstract] [Full Text] [PDF]

				D. L. Fogt, S. Pan, S. Lee, Z. Ding, A. Scrimgeour, J. C. Lawrence Jr., and J. L. Ivy Effect of glycogen synthase overexpression on insulin-stimulated muscle glucose uptake and storage Am J Physiol Endocrinol Metab, March 1, 2004; 286(3): E363 - E369. [Abstract] [Full Text]

				M. A. Selak, B. T. Storey, I. Peterside, and R. A. Simmons Impaired oxidative phosphorylation in skeletal muscle of intrauterine growth-retarded rats Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E130 - E137. [Abstract] [Full Text] [PDF]

				G. W. Cline, K. Johnson, W. Regittnig, P. Perret, E. Tozzo, L. Xiao, C. Damico, and G. I. Shulman Effects of a Novel Glycogen Synthase Kinase-3 Inhibitor on Insulin-Stimulated Glucose Metabolism in Zucker Diabetic Fatty (fa/fa) Rats Diabetes, October 1, 2002; 51(10): 2903 - 2910. [Abstract] [Full Text] [PDF]

				E. Giovannucci Insulin, Insulin-Like Growth Factors and Colon Cancer: A Review of the Evidence J. Nutr., November 1, 2001; 131(11): 3109S - 3120. [Abstract] [Full Text] [PDF]

				F. Greer, R. Hudson, R. Ross, and T. Graham Caffeine Ingestion Decreases Glucose Disposal During a Hyperinsulinemic-Euglycemic Clamp in Sedentary Humans Diabetes, October 1, 2001; 50(10): 2349 - 2354. [Abstract] [Full Text]

				J. Liu, J. A. Knezetic, L. Strömmer, J. Permert, J. Larsson, and T. E. Adrian The Intracellular Mechanism of Insulin Resistance in Pancreatic Cancer Patients J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1232 - 1238. [Abstract] [Full Text]

				G. W. Cline, K. F. Petersen, M. Krssak, J. Shen, R. S. Hundal, Z. Trajanoski, S. Inzucchi, A. Dresner, D. L. Rothman, and G. I. Shulman Impaired Glucose Transport as a Cause of Decreased Insulin-Stimulated Muscle Glycogen Synthesis in Type 2 Diabetes N. Engl. J. Med., July 22, 1999; 341(4): 240 - 246. [Abstract] [Full Text] [PDF]

				A. Nakatani, D.-H. Han, P. A. Hansen, L. A. Nolte, H. H. Host, R. C. Hickner, and J. O. Holloszy Effect of endurance exercise training on muscle glycogen supercompensation in rats J Appl Physiol, February 1, 1997; 82(2): 711 - 715. [Abstract] [Full Text] [PDF]

				M. Borkman, L. H. Storlien, D. A. Pan, A. B. Jenkins, D. J. Chisholm, and L. V. Campbell The Relation between Insulin Sensitivity and the Fatty-Acid Composition of Skeletal-Muscle Phospholipids N. Engl. J. Med., January 28, 1993; 328(4): 238 - 244. [Abstract] [Full Text]